SIRPA and cancer: Interestingly, the addition of anti-CD47 Ab or Sirpα-ex fusion protein enabled WT BMDMs to phagocytize cancer cells, but to a significantly lesser degree than Sirpα−/− BMDMs under the same stimulation.